116 related articles for article (PubMed ID: 3257179)
21. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
[TBL] [Abstract][Full Text] [Related]
22. Detection of nucleosome-IgG immune complexes in ascites from mice transplanted with anti-DNA antibody-secreting hybridomas and in plasma from MRL-lpr/lpr mice.
Fournié GJ
Clin Exp Immunol; 1996 May; 104(2):236-40. PubMed ID: 8625514
[TBL] [Abstract][Full Text] [Related]
23. Behavior and immune status of MRL mice in the postweaning period.
Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
[TBL] [Abstract][Full Text] [Related]
24. Anti-RNA polymerase I antibodies in sera of MRL lpr/lpr and MRL +/+ autoimmune mice. Correlation of antibody production with delayed onset of lupus-like disease in MRL +/+ mice.
Stetler DA; Sipes DE; Jacob ST
J Exp Med; 1985 Dec; 162(6):1760-70. PubMed ID: 3877777
[TBL] [Abstract][Full Text] [Related]
25. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
[TBL] [Abstract][Full Text] [Related]
26. Thymic influences on autoimmunity in MRL-lpr mice.
Wofsy D; Ledbetter JA; Roubinian JR; Seaman WE; Talal N
Scand J Immunol; 1982 Jul; 16(1):51-8. PubMed ID: 6981841
[TBL] [Abstract][Full Text] [Related]
27. [Studies on abnormal immune responses to thymus-dependent antigens in autoimmune MRL/MpJ-lpr/lpr mice].
Kobayashi S
Hokkaido Igaku Zasshi; 1987 May; 62(3):451-60. PubMed ID: 2956175
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
Bloksma N; de Bakker JM; van Rooijen HJ; Punt P; Seinen W; Kammüller ME
Int J Immunopharmacol; 1994 Mar; 16(3):261-8. PubMed ID: 8206693
[TBL] [Abstract][Full Text] [Related]
29. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
30. Anti-histone antibodies in the serum of autoimmune MRL and NZB/NZW1 F1 mice.
Brick JE; Ong SH; Bathon JM; Walker SE; O'Sullivan FX; DiBartolomeo AG
Clin Immunol Immunopathol; 1990 Mar; 54(3):372-81. PubMed ID: 2302840
[TBL] [Abstract][Full Text] [Related]
31. Expression of a highly conserved anti-DNA idiotype in normal and autoimmune mice.
Mayus JL; Pisetsky DS
Clin Immunol Immunopathol; 1985 Mar; 34(3):366-78. PubMed ID: 2578910
[TBL] [Abstract][Full Text] [Related]
32. Cellular interactions for the in vitro production of anti-chromatin autoantibodies in MRL/Mp-lpr/lpr mice.
Fisher CL; Shores EW; Eisenberg RA; Cohen PL
Clin Immunol Immunopathol; 1989 Feb; 50(2):231-40. PubMed ID: 2521586
[TBL] [Abstract][Full Text] [Related]
33. Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network.
Migliorini P; Ardman B; Kaburaki J; Schwartz RS
J Exp Med; 1987 Feb; 165(2):483-99. PubMed ID: 2950197
[TBL] [Abstract][Full Text] [Related]
34. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
35. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
36. VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. J558 bias is not limited to classic lupus autoantibodies.
Foster MH; MacDonald M; Barrett KJ; Madaio MP
J Immunol; 1991 Sep; 147(5):1504-11. PubMed ID: 1908876
[TBL] [Abstract][Full Text] [Related]
37. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
38. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
39. Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice.
Brick JE; Wilson DA; Walker SE
J Immunol; 1985 Jun; 134(6):3693-8. PubMed ID: 3886790
[TBL] [Abstract][Full Text] [Related]
40. Antibody feedback regulation in MRL/lpr mice.
Heyman B; Gustavsson S; Kusakari C; Nose M; Kinoshita T; Klareskog L; Tarkowski A
J Autoimmun; 1993 Aug; 6(4):437-48. PubMed ID: 8216687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
